ORAL LIQUID FORMULATION OF CANAGLIFLOZIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
The present invention relates to a liquid formulation comprising Canagliflozin or its pharmaceutically acceptable salt with one or more pharmaceutically acceptable excipient, its process for preparation and its application for the treatment of type 2 diabetes mellitus and associated cardiovascular a...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!